Novavax and the Australian government have agreed on a supply deal for NVX-CoV2373, Novavax's COVID-19 vaccine candidate, which involves the delivery of 40 million doses once it gains regulatory approval. Data from the two trials that tested the vaccine candidate in Australia have shown positive results so far.
Novavax to supply Australia with 40M COVID-19 vaccine doses
Sign up for AIChE SmartBrief
News for chemical engineers
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.